Document is current
Any future updates will be listed below
-
Authors
Grossmann, Kai
Röber, Nadja
Hiemann, Rico
Rödiger, Stefan
Schierack, Peter
Reinhold, Dirk
Laass, Martin W.
Conrad, Karsten
Roggenbuck, Dirk https://orcid.org/0000-0002-6861-6827
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (InnoProfile 03IP611, InnoProfile-Transfer 03IP611X)
- License Information
-
More Information
Article History
Received: 6 October 2015
Accepted: 9 December 2015
First Online: 30 January 2016
Compliance with ethical standards
:
: Dirk Roggenbuck has a management role and is a shareholder of GA Generic Assays GmbH and Medipan GmbH. Both companies are diagnostic manufacturers.
: The study was approved by the Local Ethics Committee (EZ151052010) and conducted in accordance with the Helsinki declaration.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: For this type of study formal consent is not required.
